Dr. Reddy's Laboratories Limited annual free cash flow for fiscal 2026 was $18.3 billion, an increase of 52.4% from $12.0 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $18.3B | $12.0B | $18.0B | $40.0B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Free Cash Flow | $4.8B | $3.6B | $5.4B | $4.5B | $10.8B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources